Fundamentals of antibody-related therapy and diagnostics

Huguette Albrecht, James A. Rodosevich, Michael Babich

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Antibodies for therapy and diagnostics form one of the fastest growing segments of the pharmaceutical market. The combination of hybridoma and recombinant DNA technologies have led to an increased production of monoclonal antibodies (MAbs), including fully human MAbs, that can be tailored for specific applications. With advances in imaging methods, MAbs are increasingly used os in vivo diagnostic tools. Therapeutic MAbs, used to treat cancer and autoimmune diseases, have proven beneficial in the clinic. An overview is presented of the history, current state and future perspectives of this emergent field.

Original languageEnglish (US)
Pages (from-to)199-211
Number of pages13
JournalDrugs of Today
Volume45
Issue number3
DOIs
StatePublished - Mar 2009

Fingerprint

Monoclonal Antibodies
Antibodies
Recombinant DNA
Hybridomas
Therapeutics
Autoimmune Diseases
History
Technology
Pharmaceutical Preparations
Neoplasms

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Albrecht, H., Rodosevich, J. A., & Babich, M. (2009). Fundamentals of antibody-related therapy and diagnostics. Drugs of Today, 45(3), 199-211. https://doi.org/101358/dot20094531341343

Fundamentals of antibody-related therapy and diagnostics. / Albrecht, Huguette; Rodosevich, James A.; Babich, Michael.

In: Drugs of Today, Vol. 45, No. 3, 03.2009, p. 199-211.

Research output: Contribution to journalArticle

Albrecht, H, Rodosevich, JA & Babich, M 2009, 'Fundamentals of antibody-related therapy and diagnostics', Drugs of Today, vol. 45, no. 3, pp. 199-211. https://doi.org/101358/dot20094531341343
Albrecht, Huguette ; Rodosevich, James A. ; Babich, Michael. / Fundamentals of antibody-related therapy and diagnostics. In: Drugs of Today. 2009 ; Vol. 45, No. 3. pp. 199-211.
@article{8e7aabcc18cd4a1599c0b11719fd802b,
title = "Fundamentals of antibody-related therapy and diagnostics",
abstract = "Antibodies for therapy and diagnostics form one of the fastest growing segments of the pharmaceutical market. The combination of hybridoma and recombinant DNA technologies have led to an increased production of monoclonal antibodies (MAbs), including fully human MAbs, that can be tailored for specific applications. With advances in imaging methods, MAbs are increasingly used os in vivo diagnostic tools. Therapeutic MAbs, used to treat cancer and autoimmune diseases, have proven beneficial in the clinic. An overview is presented of the history, current state and future perspectives of this emergent field.",
author = "Huguette Albrecht and Rodosevich, {James A.} and Michael Babich",
year = "2009",
month = "3",
doi = "101358/dot20094531341343",
language = "English (US)",
volume = "45",
pages = "199--211",
journal = "Drugs of Today",
issn = "1699-3993",
publisher = "Prous Science",
number = "3",

}

TY - JOUR

T1 - Fundamentals of antibody-related therapy and diagnostics

AU - Albrecht, Huguette

AU - Rodosevich, James A.

AU - Babich, Michael

PY - 2009/3

Y1 - 2009/3

N2 - Antibodies for therapy and diagnostics form one of the fastest growing segments of the pharmaceutical market. The combination of hybridoma and recombinant DNA technologies have led to an increased production of monoclonal antibodies (MAbs), including fully human MAbs, that can be tailored for specific applications. With advances in imaging methods, MAbs are increasingly used os in vivo diagnostic tools. Therapeutic MAbs, used to treat cancer and autoimmune diseases, have proven beneficial in the clinic. An overview is presented of the history, current state and future perspectives of this emergent field.

AB - Antibodies for therapy and diagnostics form one of the fastest growing segments of the pharmaceutical market. The combination of hybridoma and recombinant DNA technologies have led to an increased production of monoclonal antibodies (MAbs), including fully human MAbs, that can be tailored for specific applications. With advances in imaging methods, MAbs are increasingly used os in vivo diagnostic tools. Therapeutic MAbs, used to treat cancer and autoimmune diseases, have proven beneficial in the clinic. An overview is presented of the history, current state and future perspectives of this emergent field.

UR - http://www.scopus.com/inward/record.url?scp=67749143885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67749143885&partnerID=8YFLogxK

U2 - 101358/dot20094531341343

DO - 101358/dot20094531341343

M3 - Article

C2 - 19436842

AN - SCOPUS:67749143885

VL - 45

SP - 199

EP - 211

JO - Drugs of Today

JF - Drugs of Today

SN - 1699-3993

IS - 3

ER -